Dalbavancin HCl是一种半合成的脂糖肽抗生素，对革兰氏阳性细菌有杀菌活性。Dalbavancin 抑制金黄色葡萄球菌和炭疽芽孢杆菌的 MIC90分别为 0.06 μg/mL 和 0.25 μg/mL。

Dalbavancin, a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE),Dalbavancin hydrochloride inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively

171500-79-1

C88H100Cl2N10O28

1816.71

VER-001;BI 397;VER 001;A-A 1;达巴万星;BI397;BI-397;Dalbavancin HCl

DMSO:100 mg/mL (55.04 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years